Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

2articles mentioning institutions

2institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: NCT03930732 ×

NCT03930732

This institution is selected. Its supporting articles are shown below.

NCT039307322

Articles mentioning NCT03930732

2 articles · page 1 of 1

S101 Impact of dupilumab in patients with chronic obstructive pulmonary disease with cardiovascular or metabolic comorbidities: BOREAS and NOTUS trials

thoraxjnl · abstract · 2025-11-02 · 1 matching annotations

75.2%

NCT03930732 Dupilumab CVD Cardiovascular disease metD COPD

…in patients with COPD with/without CVD or metD.Methods BOREAS ( NCT03930732) and NOTUS (NCT04456673), phase 3 RCTs, enrolled patients (40– …

S174 Reduction of exacerbations according to type 2 inflammatory biomarkers with dupilumab treatment in patients with chronic obstructive pulmonary disease

thoraxjnl · abstract · 2025-11-02 · 1 matching annotations

77.4%

BOREAS NCT03930732 NOTUS dupilumab chronic obstructive pulmonary disease COPD type 2 inflammation triple inhalation therapy

…Purpose In BOREAS and NOTUS, add-on dupilumab reduced moderate-or-severe exacerba…